Crowdonomics
All companies
Monogram Orthopaedics logo

Monogram Orthopaedics

Operating

MONOGRAM ORTHOPAEDICS INC

Healthcare · Austin, NY · Founded 2016

Visit website

Linking 3D printing, machine learning, and robotics for high precision implants

Post-money valuation ⓘ
$98.6M
As of Feb 2022 · from Monogram Orthopaedics Stock 2 · pre-money + amount raised, not a traded price
Total raised
$39,125,237
Across 5 rounds since 2019
Latest share price
$7.25
Reg A Offering (2022) offering price

Financials

FY2017–FY2024 · from SEC filings · hover any figure for its source
$0
−$712K
2017
$0
−$712K
2018
$0
−$1.8M
2019
$0
−$9.1M
2020
$628K
−$11.8M
2021
$0
−$13.7M
2022
$365K
−$13.7M
2023
−$16.3M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022 audited
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
$0
$0
$628,246
$0
$364,999
—
Cost of goods sold
$0
$0
$0
$0
$458,675
$0
$17,633,028
—
Gross margin
—
—
—
—
27%
—
-4731%
—
Net income
-$712,268
-$712,268
-$1,796,265
-$9,068,006
-$11,814,968
-$13,690,947
-$13,745,217
-$16,328,000
Taxes paid
—
—
—
$0
$0
$0
$0
$0
Balance sheet
Cash
$922,108
$922,108
$2,319,393
$5,586,748
$5,535,710
$10,468,645
$13,589,028
$15,658,000
Accounts receivable
$0
$0
$0
$0
$0
$0
$364,999
—
Total assets
$1,184,254
$1,184,254
$2,620,141
$8,115,888
$8,715,366
$13,690,063
$16,579,008
$17,770,000
Short-term debt
—
—
—
$0
$0
$0
—
—
Long-term debt
$180,000
$223,000
$48,000
$0
$0
$0
$0
—
Total liabilities
$2,575,280
$2,575,280
$2,894,773
$0
$5,911,236
$9,540,886
$3,181,942
$3,267,000
Other
Headcount
2
2
12
—
23
27
28
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$36.5M
post-money
$98.6M
post-money
Reg A Offering (2019)
Monogram Orthopaedics Stock 2

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg A Offering (2024)WithdrawnReg A+ · Equity
Raised $0
Reg A Offering (2022)ClosedReg A+ · Equity · via Digital Offering LLC
Raised $233.4K / $30MInvestors 121
Reg CF Offering (2022)ClosedReg CF · Preferred Equity · via DEALMAKER SECURITIES LLC
Raised $0 / $5M
Monogram Orthopaedics Stock 2ClosedReg A+ · Common Equity · via StartEngine
Raised $23.6M / $30MInvestors 14,102Post-money $98.6M
Reg A Offering (2019)ClosedReg A+ · Equity · via SeedInvest
Raised $15.3M / $20MInvestors 7,670Post-money $36.5M

Team

8 people
/s/Benjamin Sexson
CEO
Benjamin Sexson
Chief Executive Officer, President
Kamran Shamaei, PhD
Chief Technology Officer
Noel Knape
Chief Financial Officer
Colleen Gray*
Director (Class I)
Dr. Douglas Unis
Director (Class III)
Paul Riss*
Director (Class II)
Rick Van Kirk*
Director (Class I)

Names and titles as disclosed on SEC Form C, SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

14,102 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 50 filings on EDGAR
  • Form 10-QAug 15, 20250001410578-25-001836
    EDGAR
  • Form 10-QMay 14, 20250001410578-25-001264
    EDGAR
  • Form 10-KMar 12, 20250001410578-25-000321
    EDGAR
  • Form 10-QNov 14, 20240001410578-24-001996
    EDGAR
  • Form 10-QAug 15, 20240001410578-24-001488
    EDGAR
  • Form 1-A-WJun 3, 20240001104659-24-067825
    EDGAR
  • Form 10-QMay 14, 20240001410578-24-000765
    EDGAR
  • Form 1-A/AMay 8, 20240001104659-24-058785
    EDGAR
Source: ManualCIK 0001769759DEShare price $7.25

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.